High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Annette Wundes, MD
Department of Neurology, University of Washington
Study Chair - George E. Georges, MD
Fred Hutchinson Cancer Research Center, Clinical Research Division, University of Washington
Study Chair - George H. Kraft, MD
Departments of Neurology and Rehabilitation Medicine, University of Washington
Study Chair - George J. Hutton, MD
The Maxine Messinger Multiple Sclerosis Clinic, The Methodist Hospital, Baylor College of Medicine
Study Chair - James D. Bowen, MD
Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, Washington
Study Chair - Michael K. Racke, MD
Department of Neurology, Ohio State University Medical Center
Study Chair - Richard A. Nash, MD
Blood and Marrow Transplant Program, Colorado Blood Cancer Institute, Presbyterian/St. Luke's Medical Center, Denver
Study Chair - Steven M. Devine, MD
Department of Hematology and Oncology, Ohio State University Medical Center
Study Chair - Uday Popat, MD
Department of Blood and Marrow Transplantation, University of Texas, M.D. Anderson Cancer Center
Study ChairKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ohio State University School of Medicine
Columbus, Ohio, United States
- Baylor College of Medicine
Houston, Texas, United States
- M.D. Anderson Cancer Center; Transplant Site, Please Contact Baylor College of Medicine
Houston, Texas, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2006
- Primary completion
- 30 Nov 2015
- Completion
- 30 Nov 2015
- Last update posted
- 19 Sept 2017
- Registered enrollment
- 25
- Registry id
- NCT00288626
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.